Bevacizumab intravítreo como tratamiento en pacientes con edema macular por oclusión de vena central de la retina
Date
2008
Director(es) - Asesor(es)
Journal Title
Journal ISSN
Volume Title
Publisher
Fundación Universitaria San Martín
Abstract
Abstract
Purpose: To evaluate the functional and anatomical effect of bevacizumab in patients with macular edema secondary to nonischemic central retinal vein occlusion.
Materials and Methods: Interventional case series study in 29 eyes with macula edema secondary to non-ischemic central retinal vein occlusion treated with 2.5 mg intravitreal Bevacizumab injection. Visual acuity, macular thickness measured with OCT and secondary effects were evaluated at presentation, 3 and 6 months after treatment.
Results: We found a statistically significant difference on the macular thickness before and after intravitreal Bevacizumab injection. There is no significant difference on visual acuity before and after treatment.
Conclusions: Intravitreal Bevacizumab seems to have significant effect on macular thickness and fewer effects on visual acuity in patients with CRVO.
Description
Keywords
Oclusión de la vena central de la retina, Edema macular, Bevacizumab intravítreo